OrganiGram Cash Conversion Cycle from 2010 to 2026
| OGI Stock | USD 1.27 0.02 1.55% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter 203.68313853 | Current Value 291.4 | Quarterly Volatility 95.50058513 |
Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as Interest Expense of 303.5 K, Selling General Administrative of 67.4 M or Other Operating Expenses of 301.3 M, as well as many indicators such as Price To Sales Ratio of 2.86, Dividend Yield of 0.0 or PTB Ratio of 0.82. OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.
OrganiGram | Cash Conversion Cycle | Build AI portfolio with OrganiGram Stock |
The Cash Conversion Cycle trend for OrganiGram Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether OrganiGram Holdings is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest OrganiGram Holdings' Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of OrganiGram Holdings over the last few years. It is OrganiGram Holdings' Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OrganiGram Holdings' overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
OrganiGram Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | 202.88 | |
| Geometric Mean | 168.01 | |
| Coefficient Of Variation | 47.07 | |
| Mean Deviation | 80.18 | |
| Median | 268.68 | |
| Standard Deviation | 95.50 | |
| Sample Variance | 9,120 | |
| Range | 243 | |
| R-Value | 0.56 | |
| Mean Square Error | 6,636 | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 10.66 | |
| Total Sum of Squares | 145,926 |
OrganiGram Cash Conversion Cycle History
About OrganiGram Holdings Financial Statements
Investors use fundamental indicators, such as OrganiGram Holdings' Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | 203.68 | 291.40 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of OrganiGram Holdings Correlation against competitors. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Pharmaceuticals market expansion? Will OrganiGram introduce new products? Factors like these will boost the valuation of OrganiGram Holdings. Anticipated expansion of OrganiGram directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.11 | Revenue Per Share | Quarterly Revenue Growth 0.487 | Return On Assets | Return On Equity |
Investors evaluate OrganiGram Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating OrganiGram Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause OrganiGram Holdings' market price to deviate significantly from intrinsic value.
It's important to distinguish between OrganiGram Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OrganiGram Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, OrganiGram Holdings' market price signifies the transaction level at which participants voluntarily complete trades.